Skip to main content
Log in

Concentration of monoamines and their metabolites in the cerebrospinal fluid from patients with senile dementia of the Alzheimer type and vascular dementia of the Binswanger type

  • Full Papers
  • Published:
Journal of Neural Transmission - Parkinson's Disease and Dementia Section

Summary

We measured the concentrations of total (conjugated and unconjugated) monoamines (dopamine, DA; norepinephrine, NE) and monoamine metabolites (homovanillic acid, HVA; 3-methoxy-4-hydroxyphenyleneglycol, MHPG; 5-hydroxyindoleacetic acid, 5-HIAA) in the cerebrospinal fluid (CSF), using HPLC-ECD in 11 patients with Alzheimer's disease (AD) or senile dementia of the Alzheimer type (SDAT), 17 patients with vascular dementia of the Binswanger type (VDBT), and 15 controls. In AD/SDAT, there was a significant decrease in the DA concentration and a significant increase in the MHPG concentration. The average NE concentration was not altered, but significantly increased with the progression of intellectual disability. There were no significant changes in HVA and 5-HIAA concentrations. Patients with VDBT showed a significant increase in the DA concentration and a significant decrease in HVA and 5-HIAA concentrations. The DA concentrations increased significantly with the progression of dementia and ventricular enlargement. These results indicate that the noradrenergic and dopaminergic system in particular are altered in AD/SDAT, while the dopaminergic and serotonergic systems are mainly involved in VDBT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Adolfsson R, Gottfries CG, Ross BE, Winblad B (1979) Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br J Psychiatry 135: 216–223

    Google Scholar 

  • American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd ed (revised). APA, Washington DC, pp 21–23

    Google Scholar 

  • Argentiero V, Tavolato B (1980) Dopamine (DA) and serotonin metabolic levels in the cerebrospinal fluid (CSF) in Alzheimer's presenile dementia under basic conditions and after stimulation with cerebral cortex phospholipids (BC-PL). J Neurol 224: 53–58

    Google Scholar 

  • Bareggi SR, Franceschi M, Bonini L, Zecca L, Smirne S (1982) Decreased CSF concentrations of homovanillic acid and α-aminobutyric acid in Alzheimer's disease. Age- or disease-related modification?. Arch Neurol 39:709–712

    Google Scholar 

  • Bartholini G, Pletscher A, Tissot R (1966) On the origin of homovanillic acid in the cerebrospinal fluid. Experientia 22: 609–610

    Google Scholar 

  • Björklund A, Divac I, Lindvall O (1978) Regional distribution of catecholamines in monkey cerebral cortex, evidence for a dopaminergic innervation of the primate prefrontal cortex. Neurosci Lett 7: 115–119

    Google Scholar 

  • Bowen DD, Sims NR, Benton JS, Curzon G, Davison AN (1981) Treatment of Alzheimer's disease: a cautionary note. N Engl J Med 305: 1016

    Google Scholar 

  • Bråne G, Gottfries CG, Blennow K, Karlsson I, Lekman A, Parnetti L, Svennerholm L, Wallin A (1989) Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset Alzheimer dementia. Alzheimer Disease and Associated Disorders 3: 148–156

    Google Scholar 

  • Brun A, Gustafson L (1976) Distribution of cerebral degeneration in Alzheimer's disease. A clinicopathological study. Arch Psychiat Nervenkr 223:15–33

    Google Scholar 

  • Carlsson A (1983) Changes in neurotransmitter systems in the aging brain and in Alzheimer's disease. In: Reisberg B (ed) Alzheimer's disease. Macmillan, New York, pp 100–106

    Google Scholar 

  • Christensen A-L (1990) Neuropsychological approach to Alzheimer's dementia. In: Hasegawa K, Homma A (eds) Psychogeriatrics. Biomedical and social advances. Excerpta Medica, Amsterdam Princetom Hong Kong Tokyo Sydney, pp 169–174

    Google Scholar 

  • Cross AJ, Grow TJ, Perry EK, Perry RH, Blessed G, Tomlinson BE (1981) Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease. Br Med J 282: 93–94

    Google Scholar 

  • Cross AJ, Grow TJ, Johnson JA, Joseph MH, Perry EK, Perry RH, Blessed G, Tomlinson BE (1983) Monoamine metabolism in senile dementia of Alzheimer type. J Neurol Sci 60:383–392

    Google Scholar 

  • Folstein MF, Folstein SE, McHugh PR (1975) “Mini-Mental State”. A practical method of grading. The cognitive state of patients for the clinician. J Psychiatr Res 12:189–198

    Google Scholar 

  • Gottfries CG, Gottfries I, Roos BE (1969) Homovanillic acid and 5-hydroxyindoleactic acid in the cerebrospinal fluid of patients with senile dementia, presenile dementia and parkinsonism. J Neurochem 16: 1341–1345

    Google Scholar 

  • Gottfries CG, Gottfries I, Roos BE (1970) Homovanillic acid and 5-hydroxyindoleacetic acid cerebrospinal fluid related to rated mental and motor impairment in senile and presenile dementia. Acta Psychiatr Scand 46: 99–105

    Google Scholar 

  • Guard O, Renaud B, Chazot G (1976) Métabolisme cérébral de la dopamine et de la sérotonine au cours des maladies d'Alzheimer et de Pick. Etude dynamique par le test au probénécide. Encephale 2: 293–303

    Google Scholar 

  • Hachinski VC, Iliff LD, Zilhka E, Du Boulay GH, McAllister VL, Marshall J, Ross Russell RW, Symon L (1975) Cerebral blood flow in dementia. Arch Neurol 32: 632–637

    Google Scholar 

  • Hasegawa K, Inoue K, Moriya K (1974) An investigation of dementia rating scale for the elderly. Clin Psychiatry 16: 965–969 (in Japanese)

    Google Scholar 

  • Jagust WJ, Budinger TF, Reed BR (1987) The diagnosis of dementia with single photon emission computed tomography. Arch Neurol 44:258–262

    Google Scholar 

  • Kopin IJ, Gordon EK, Jimerson DC, Polinsky RJ (1983) Relation between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylglycol. Science 219: 73–75

    Google Scholar 

  • Lotz PR, Ballinger WE Jr, Quisling RG (1986) Subcortical arteriosclerotic encephalopathy: CT spectrum and pathologic correlation. AJNR 7:817–822

    Google Scholar 

  • Mann DMA, Lincoln J, Yates PO, Stamp JE, Toper S (1980) Changes in the monoamine containing neurons of the human CNS in senile dementia. Br J Psychiatry 136: 533–541

    Google Scholar 

  • Mann DMA, Yates PO, Hawkes J (1982) The noradrenergic system in Alzheimer and multi-infarct dementias. J Neurol Neurosurg Psychiatry 45: 113–119

    Google Scholar 

  • McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939–944

    Google Scholar 

  • Meese W, Lanksch W, Wende S (1976) Cerebral atrophy and computerized tomography-Aspects of a qualitative and quantitative analysis. In: Lanksch W, Kazner E (eds) Cranial computerized tomography. Springer, Berlin Heidelberg New York, pp 222–232

    Google Scholar 

  • Molliver ME, Grzanna R, Lidov HGW, Morrison JH, Olschowka JA (1982) Monoamine systems in the cerebral cortex. In: Chan-Palay V, Palay B (eds) Cytochemical methods in neuroanatomy. Alan R Liss, New York, pp 255–277

    Google Scholar 

  • Palmer AM, Sims NR, Bowen DM, Neary D, Palo J, Wikstrom J, Davison AN (1984) Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia. J Neurol Neurosurg Psychiatry 47:481–484

    Google Scholar 

  • Parnetti L, Gottfries J, Karlsson I, Långström G, Gottfries C-G, Svennerholm L (1987) Monoamines and their metabolites in cerebrospinal fluid of patients with senile dementia of Alzheimer type using high performance liquid chromatography and gas chromatography-mass spectrometry. Acta Psychiatr Scand 75: 542–548

    Google Scholar 

  • Pastuszko A, Wilson DF, Ercińska M (1982) Neurotransmitter metabolism in rat brain synaptosomes: effect of anoxia and pH. J Neurochem 38: 1657–1667

    Google Scholar 

  • Raskind MA, Peskind ER, Halter JB, Jimerson DC (1984) Norepinephrine and MHPG levels in CSF and plasma in Alzheimer's disease. Arch Gen Psychiatry 41: 343–346

    Google Scholar 

  • Román GC (1987) Senile dementia of the Binswanger type. A vascular form of dementia in the elderly. JAMA 258: 1782–1788

    Google Scholar 

  • Siesjö BK (1978) Brain energy metabolism and catecholaminergic activity in hypoxia, hypercapnia and ischemia J Neural Transm 14[Suppl]: 17–22

    Google Scholar 

  • Slivka A, Brannan TS, Weinberger J, Knott PJ, Cohen G (1988) Increase in extracellular dopamine in the striatum during cerebral ischemia: a study utilizing cerebral microdialysis. J Neurochem 50:1714–1718

    Google Scholar 

  • Smirne S, Franceschi M, Truci G, Camerlingo M, Pirola R, Ferini-Strambi L, Bareggi SR (1985) Homovanillic acid and 5-hydroxyindoleacetic acid modifications in CSF of patients with stroke and multi-infarct dementia. Stroke 16: 1003–1005

    Google Scholar 

  • Soininen H, MacDonald E, Rekonen M, Riekkinen PJ (1981) Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type. Acta Neurol Scand 64: 101–107

    Google Scholar 

  • Tomlinson BE, Irving D, Blessed G (1981) Cell loss in the locus coeruleus in senile dementia of Alzheimer type. J Neurol Sci 49: 419–428

    Google Scholar 

  • Tyce GM, Rorie DK, Byer DE, Danielson DR (1985) Free and conjugated amines in human lumbar cerebrospinal fluid. J Neurochem 49: 322–324

    Google Scholar 

  • Weinberger J, Cohen G (1982) The differential effect of ischemia on the active uptake of dopamine, γ-aminobutyric acid, and glutamate by brain synaptosomes. J Neurochem 38: 963–968

    Google Scholar 

  • Wester P, Bergström U, Eriksson A, Gezelius C, Hardy J, Winblad B (1990) Ventricular cerebrospinal fluid monoamine transmitter and metabolite concentrations reflect human brain neurochemistry in autopsy cases. J Neurochem 54: 1148–1156

    Google Scholar 

  • Winblad B, Adolfsson R, Carlsson A, Gottfries CG (1982) Biogenic amines in brains of patients with Alzheimer's disease. In: Corkin, S, Davis KL, Growdon JH, Usolin E, Wurtman RJ (eds) Alzheimer's disease: a report of progress in research. Raven Press, New York, pp 25–33

    Google Scholar 

  • Wolfe N, Linn R, Babikian VL, Knoefel JE, Albert ML (1990) Frontal systems impairment following multiple lacunar infarcts. Arch Neurol 47: 129–132

    Google Scholar 

  • Wood PL, Etienne P, Lal S, Gauthier S, Cajal S, Nair NPV (1982) Reduced lumbar CSF somatostantin levels in Alzheimer's disease. Life Sci 31: 2073–2079

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tohgi, H., Ueno, M., Abe, T. et al. Concentration of monoamines and their metabolites in the cerebrospinal fluid from patients with senile dementia of the Alzheimer type and vascular dementia of the Binswanger type. J Neural Transm Gen Sect 4, 69–77 (1992). https://doi.org/10.1007/BF02257623

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02257623

Keywords

Navigation